FBLG - FibroBiologics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.42 0.04 (8.34%)	---	---	0.0 (-0.63%)	0.0 (0.82%)	0.04 (9.68%)	0.01 (1.61%)	0.01 (1.61%)

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.12
Diluted EPS:: -0.12
Basic P/E:: -3.8325
Diluted P/E:: -3.8325
RSI(14) 1m:: 100.0
VWAP:: 0.46
RVol:: 1.521

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	0.46 +0.0 (+1.01%)	Oct 15 15:54
1m	Price increase 1m	0.47 +0.01 (+1.69%)	Oct 15 15:34
1m	Price increase 1m	0.47 +0.01 (+1.26%)	Oct 15 15:33
1m	Price decrease 1m	0.46 -0.01 (-2.12%)	Oct 15 15:32
1m	Price increase 1m	0.47 +0.01 (+1.09%)	Oct 15 15:30